B.K. Corkey et al. / Tetrahedron xxx (2013) 1e7
5
bicarbonate (5 mL) and extracted with diethyl ether. Flash chro-
matography (hexanes/ethyl acetate 50:1) gave acetal 3 as a volatile
oil (9 mg, 46%). Chiraldex G-TA; 90 ꢀC hold 0 min, then 5 ꢀC/min to
150 ꢀC; 2.0 mL/min He carrier gas, tM¼9.5 min, tm¼8.9 min, 66% ee.
J¼7, 2.1 Hz, 1H), 7.26 (m, 2H), 4.82 (t, J¼2.3 Hz, 1H), 4.35 (t, J¼2.3 Hz,
1H), 2.71 (m, 2H), 2.00e2.20 (m, 4H). 13C NMR (126 MHz, CDCl3)
d
176.2, 155.3,149.2, 144.2, 127.7, 126.4, 122.0, 120.8, 107.9, 68.1, 34.7,
33.8, 25.1. HRMS (EI): calcd for [C13H13N]þ: 183.1048, found
183.1047. HPLC Chiralcel AD column (98:2 hexanes/isopropanol,
1.0 mL/min): tM¼10.5 min, tm¼9.8 min: 71% ee.
1H NMR (500 MHz, CDCl3)
d 4.97 (s, 1H), 4.94 (s, 1H), 4.15 (s, 1H),
3.92 (m, 1H), 3.54 (m, 1H), 3.38 (s, 3H), 2.47 (m, 2H), 1.97 (m, 1H),
1.68 (m, 1H), 1.66e1.48 (m, 6H). 13C NMR (75.5 MHz, CDCl3)
d 157.7,
107.5, 105.5, 64.5, 56.5, 49.0, 34.7, 33.7, 33.6, 23.2, 22.6.
4.4.10. 4-Methyl-N-((1-methyl-2-methylenecyclopentyl)methylene)
benzenesulfonamide (9). Yield 75%. 1H NMR (300 MHz, CDCl3)
4.4.2. 6-Methylene-2-tosyl-2-azaspiro[4.4]nonane (5b). The racemic
product has been characterized previously.7a Yield 59%. HPLC Chir-
alcel AD column (95:5 hexanes/ethanol, 1.0 mL/min): tM¼16.1 min,
tm¼20.9 min: 84% ee.
d
8.32 (s, 1H), 7.78 (d, J¼8.1 Hz, 2H), 7.32 (d, J¼8.1 Hz, 2H), 5.05 (br s,
1H), 4.69 (br s, 1H), 2.30e2.55 (m, 2H), 2.43 (s, 3H), 2.09 (m, 1H),
1.80e1.60 (m, 3H), 1.24 (s, 3H). 13C NMR (126 MHz, CDCl3)
180.4,
d
154.8, 144.2, 135.0, 129.7, 127.9, 109.8, 51.8, 37.6, 33.4, 23.6, 22.9,
21.6. HRMS (EI): calcd for [C15H19NO2S]þ: 277.1137, found 277.1143.
HPLC Chiralcel AD column (95:5 hexanes/ethanol, 1.0 mL/min):
tM¼10.2 min, tm¼9.5 min: 64% ee.
4.4.3. 1-Methylene-7-tosyl-7-azaspiro[4.5]decane (5c). The racemic
product has been characterized previously.7a Yield 71%. HPLC Chir-
alcel AD column (95:5 hexanes/ethanol, 1.0 mL/min): tM¼9.2 min,
tm¼10.9 min: 93% ee.
4.5. Procedures and characterization of intermediates for the
synthesis of the kopsifoline core
4.4.4. 1-Methylene-7-tosyl-7-azaspiro[4.6]undecane (5d). The race-
mic product has been characterized previously.7a Yield 70%. Chir-
alcel AD column (98:2 hexanes/ethanol, 1.0 mL/min): tM¼12.2 min,
tm¼14.7 min: >99% ee.
4.5.1. 1-((2-Nitrophenyl)sulfonyl)-5-(pent-4-yn-1-yl)-1,2,3,4-
tetrahydropyridine (4a). The title compound was synthesized in
four steps from valerolactam (33% overall yield) in analogy to
procedures previously reported.7a
4.4.5. 5-(2-Ethynylbenzyl)-1-(2-nitrophenylsulfonyl)-1,2,3,4-
1H NMR (500 MHz, CDCl3)
d
7.95 (dd, J¼7.0, 1.5 Hz, 1H), 7.70 (m,
tetrahydropyridine (4e). 1H NMR (400 MHz, CDCl3)
d
7.94 (d, 1H,
2H), 7.61 (dd, J¼7.0, 1.5 Hz, 1H), 3.50 (m, 2H), 2.15 (m, 4H), 1.98 (t,
J¼2.5 Hz, 1H), 1.94 (t, J¼6.0 Hz, 2H), 1.78 (quint, J¼6.0 Hz, 2H). 1.65
J¼7.6 Hz), 7.58e7.74 (m, 3H), 7.48 (d, 1H, J¼8.0 Hz), 7.25e7.31 (m,
1H), 7.23e7.17 (m,1H), 6.58 (s,1H), 3.52 (s, 2H), 3.47 (m, 2H), 3.01 (s,
1H), 1.94 (t, 2H, J¼6.4 Hz), 1.74 (quint, 2H, J¼6.0 Hz). 13C NMR
(quint, J¼7.5 Hz, 2H). 13C NMR (126 MHz, CDCl3)
d 148.2, 133.7,
131.6, 130.4,124.0, 120.7, 119.4, 84.0, 68.8, 43.9, 34.0, 26.2, 24.4, 21.2,
17.7. HRMS (FAB): calcd for [C16H19N2O4S]þ: 334.09873, found
334.09824.
(100 MHz, CDCl3)
d 141.6, 133.6, 132.9, 131.7, 130.4, 129.0, 126.3,
124.0, 122.0, 120.7, 82.3, 81.2, 43.8, 39.5, 24.3, 21.1. HRMS (FAB):
calcd for [C20H19N2O4S]þ: 383.1060, found: 383.1070.
4.5.2. 6-Methoxy-1-methylene-7-((2-nitrophenyl)sulfonyl)-7-
azaspiro[4.5]decane (5a0, major diastereomer). To a solution of 3a
(980 mg, 2.93 mmol) in diethyl ether (200 mL), acetic acid (19 mL)
and methanol (3.2 mL) was added ((R)-binaphane)Pd(OTf)2(OH2)2
(35 mg, 1 mol %). After 21 h the reaction was carefully quenched
with slow addition of saturated sodium bicarbonate solution
(250 mL). Concentration afforded the crude product as a 10:1
mixture of diastereomers, which were separated by flash chroma-
tography (5:1 hexanes/ethyl acetate) to give the title product
(840 mg, 78%) as a light yellow oil.
4.4.6. 1-Methylene-10-((2-nitrophenyl)sulfonyl)-1,3-dihydrospiro[in-
dene-2,30-piperidine] (5e). Yield 73%: 1H NMR (300 MHz, CDCl3)
d
7.93e7.88 (m,1H), 7.60e7.75 (m, 3H), 7.48e7.42 (m,1H), 7.10e7.30
(m, 3H), 5.60 (s, 1H), 4.97 (s, 1H), 3.91e4.05 (m, 1H), 3.57 (d,
J¼12.0 Hz, 1H), 2.60e2.90 (m, 3H), 1.55e2.00 (m, 4H). 13C NMR
(75 MHz, CDCl3) d 155.4, 143.1, 139.6, 133.6, 131.9, 131.6, 131.1, 129.2,
126.9, 125.8, 124.1, 121.0, 103.7, 55.9, 46.5, 46.4, 41.0, 35.0, 22.6.
4.4.7. 1-(Naphthalen-1-ylsulfonyl)-5-(pent-4-yn-1-yl)-1,2,3,4-
tetrahydropyridine (4f). 1H NMR (500 MHz, CDCl3): 1H NMR
[
a
]
þ32.3 (CHCl3, c 1.0 g/100 mL). HPLC Chiralcel AD column
D
(500 MHz, CDCl3)
d
8.36 (s, 1H), 7.87e8.03 (m, 3H), 7.76 (dd, J¼8.7,
(99:01 hexanes/isopropanol, 1.0 mL/min): tM¼21.5 min,
1.7 Hz, 1H), 7.57e7.68 (m, 2H), 6.60 (s, 1H), 3.32e3.40 (m, 2H),
2.04e2.15 (m, 4H), 1.96e2.02 (m, 1H), 1.79 (t, J¼6.1 Hz, 2H),
1.52e1.64 (m, 4H). 13C NMR (126 MHz): 135.0, 134.9, 132.3, 129.4
(two peaks), 128.9, 128.5, 128.1, 127.7, 122.6, 120.6, 120.2, 84.1, 69.0,
43.8, 34.0, 26.3, 24.4, 21.0, 17.6. HRMS (ESIþ): calcd for
[C20H21O2NSþH]þ: 340.1366, found: 340.1368.
tm¼24.1 min: 90% ee. 1H NMR (300 MHz, CDCl3)
d 8.00 (m, 1H),
7.58e7.71 (m, 3H), 4.98 (m, 2H), 4.56 (s, 1H), 3.70 (dd, J¼12.0,
3.9 Hz, 1H), 3.19 (dt, J¼12.6, 3.6 Hz, 1H), 3.15 (s, 3H), 2.38 (m, 2H),
2.02 (dt, J¼12.6, 4.8 Hz, 1H), 1.18e1.82 (m, 7H). 13C NMR (126 MHz,
CDCl3)
d 154.7, 148.2, 134.5, 133.6, 132.0, 130.3, 124.4, 109.5, 89.1,
57.9, 50.3, 41.2, 35.5, 33.8, 29.7, 22.8, 22.2. HRMS (FAB): calcd for
[C16H19N2O4S]þ (loss of methoxide): 335.10655, found: 335.10643.
4.4.8. 1-Methylene-7-(naphthalen-1-ylsulfonyl)-7-azaspiro[4.5]dec-
ane (5f). Yield 62%. 1H NMR (500 MHz, CDCl3)
d
8.31e8.32 (m, 1H),
4.5.3. 6-Methoxy-7-((2-nitrophenyl)sulfonyl)-7-azaspiro[4.5]decan-
1-one (12, major diastereomer). A solution of 5a0 (750 mg,
2.05 mmol) in methanol (50 mL) was subjected to a stream of ozone
at ꢁ78 ꢀC for 5 min. Dimethyl sulfide was added, and the solution
was allowed to come to room temperature. Concentration yielded
a colorless oil, which was taken into dichloromethane (100 mL),
washed with water (3ꢂ200 mL), and dried over MgSO4. Concen-
tration gave the title product (740 mg, 98%) as a white foam.
7.97 (t, J¼7.5 Hz, 2H), 7.92 (d, J¼7.8 Hz, 1H), 7.73 (dd, J¼8.6, 1.8 Hz,
1H), 7.59e7.68 (m, 2H), 4.91 (t, J¼2.0 Hz, 1H), 4.66 (t, J¼2.2 Hz, 1H),
3.77e3.84 (m, 1H), 3.44 (d, J¼11.4 Hz, 1H), 2.26e2.50 (m, 3H),
2.10e2.16 (m, 1H), 2.06 (d, J¼11.5 Hz, 1H), 1.62e1.83 (m, 4H),
1.39e1.52 (m, 2H), 1.21e1.35 (m, 1H). 13C NMR (126 MHz, CDCl3)
d
158.0, 134.9, 133.9, 132.4, 129.4, 129.3, 128.8, 128.0, 127.6, 123.1,
105.8, 55.0, 46.7, 45.6, 35.8, 35.3, 33.9, 22.9, 22.6. HRMS (ESIþ):
calcd for [C20H23O2NSþH]þ: 342.1522, found: 342.1531. HPLC
Chiralcel AD column (99:1 hexanes/isopropanol, 1.0 mL/min):
tM¼28.6 min, tm¼35.7 min: 93% ee.
[a
]
þ41.7 (CHCl3, c 0.75 g/100 mL). 1H NMR (500 MHz, CDCl3)
D
d
8.02 (d, J¼7.0 Hz, 1H), 7.71 (m, 2H), 7.63 (d, J¼7.0, 1H), 4.88 (s, 1H),
3.77 (br d, J¼12.0 Hz, 1H), 3.19 (dt, J¼13.0, 3.5 Hz, 1H), 3.06 (s, 3H),
2.45 (m, 1H), 2.24 (m, 3H), 1.91 (m, 2H), 1.50e1.52 (m, 3H), 1.17 (d,
4.4.9. 2-Methylenespiro[cyclopentane-1,10-indene] (7). Yield 41%. 1H
J¼13.5 Hz, 1H). 13C NMR (126 MHz, CDCl3)
d 216.6, 147.8, 133.9,
NMR (400 MHz, CDCl3)
d
7.98 (s, 1H), 7.60 (d, J¼8 Hz, 1H), 7.34 (dt,
131.8, 130.2, 124.2, 85.1, 56.6, 53.4, 40.9, 37.1, 32.3, 25.4, 21.8, 17.6.